Download PDF
Horm Metab Res
DOI: 10.1055/a-2441-5132
Original Article: Endocrine Care

Association of Circulating Homocysteine Level with the Risk of Nephropathy in Type 2 Diabetes Mellitus: A Meta-Analysis

Manli Zhu
1   Central Laboratory, Xinjiang Medical University, Urumqi, China
,
Yandong Fan 
2   Department of Neurosurgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
› Author AffiliationsSupported by: The Natural Science Foundation Project of the Xinjiang Uygur Autonomous Region 2019D01C189
› Further Information
Also available at
    Permissions and Reprints

Abstract

The objective of the study was to explore the association between homocysteine (Hcy) levels and the risk of type 2 diabetic nephropathy (T2DN). PubMed, Web of Science, Cochrane Library, and Embase databases were searched to collect literature on the association between Hcy levels and the risk of T2DN. The retrieval period was from the establishment of the database to September 10, 2024. Stata 15.0 statistical software was used for data analysis. Type II diabetes without nephropathy was considered the control group, and microalbuminuria and macroalbuminuria were included in the experimental group. Fourteen articles were included in this meta-analysis. The results of the meta-analysis showed that compared with the control group, the level of Hcy in the T2DN group with microalbuminuria [Weighted mean difference (WMD)=2.50, 95% confidence interval (CI): 1.49–3.51, p<0.001] and the group with macroalbuminuria (WMD=3.38, 95% CI: 1.95–4.82) was significantly increased. Compared with the T2DN microalbuminuria group, the Hcy level in the T2DN macroalbuminuria group was considerably higher (WMD=2.12, 95% CI: 0.80–3.44, p<0.001). High homocysteine levels were associated with an increased risk of T2DN (OR=1.36, 95% CI: 1.20–1.54, p<0.001). In conclusion, circulating Hcy levels are significantly associated with the severity of T2DN. In addition, there was a significant association between high Hcy levels and an increased risk of T2DN.

Keywords

meta-analysis - homocysteine - type 2 diabetes mellitus


Publication History

Received: 13 September 2024

Accepted after revision: 11 October 2024

Article published online:
21 November 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Lin YC, Chang YH, Yang SY. et al. Update of pathophysiology and management of diabetic kidney disease. J Formos Med Assoc 2018; 117: 662-675
    CrossrefPubMedSearch in Google Scholar
  • 2 Sagoo MK, Gnudi L. Diabetic kidney disease: an overview. Meth Mol Biol 2020; 2067: 3-7
    CrossrefPubMedSearch in Google Scholar
  • 3 Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020 22. 3-15
    PubMedSearch in Google Scholar
  • 4 Kaur L, Garg PR, Ghosh PK. et al. Impaired homocysteine metabolism associated with high plasma interleukin-17A levels, a pro-atherogenic marker, in an endogamous population of North India. Ethnic Dis 2018; 28: 525-530
    CrossrefPubMedSearch in Google Scholar
  • 5 Kaplan P, Tatarkova Z, Sivonova MK. et al. Homocysteine and mitochondria in cardiovascular and cerebrovascular systems. Int J Mol Sci 2020; 21: 7698
    CrossrefPubMedSearch in Google Scholar
  • 6 Zhao W, Gao F, Lv L. et al. The interaction of hypertension and homocysteine increases the risk of mortality among middle-aged and older population in the United States. J Hypertens 2022; 40: 254-263
    CrossrefPubMedSearch in Google Scholar
  • 7 Muzurović E, Kraljević I, Solak M. et al. Homocysteine and diabetes: role in macrovascular and microvascular complications. J Diabetes Complicat 2021; 35: 107834
    CrossrefPubMedSearch in Google Scholar
  • 8 Cheng Y, Jin Y, Unverzagt FW. et al. The relationship between cholesterol and cognitive function is homocysteine-dependent. Clin Interv Aging 2014; 9: 1823-1829
    PubMedSearch in Google Scholar
  • 9 Zhang SF, Li LZ, Zhang W. et al. Association between plasma homocysteine levels and subclinical hypothyroidism in adult subjects: a meta-analysis. Horm Metab Res 2020; 52: 625-638
    Thieme ConnectPubMedSearch in Google Scholar
  • 10 Ma SC, Hao YJ, Jiao Y. et al. Homocysteine‑induced oxidative stress through TLR4/NF‑κB/DNMT1‑mediated LOX‑1 DNA methylation in endothelial cells. Mol Med Rep 2017; 16: 9181-9988
    CrossrefPubMedSearch in Google Scholar
  • 11 Mattson MP, Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 2003; 26: 137-146
    CrossrefPubMedSearch in Google Scholar
  • 12 Chen X, Shi C, Wang Y. et al. The mechanisms of glycolipid metabolism disorder on vascular injury in type 2 diabetes. Front Physiol 2022; 13: 952445
    CrossrefPubMedSearch in Google Scholar
  • 13 Mao S, Xiang W, Huang S. et al. Association between homocysteine status and the risk of nephropathy in type 2 diabetes mellitus. Clin Chim Acta 2014; 431: 206-210
    CrossrefPubMedSearch in Google Scholar
  • 14 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg (London, England) 2010; 8: 336-341
    CrossrefPubMedSearch in Google Scholar
  • 15 Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-605
    CrossrefPubMedSearch in Google Scholar
  • 16 Rostom A, Dube C, Cranney A. Agency for healthcare research and quality evidence reports summaries. University of Ottawa Evidence-Based Practice center. Ottawa, Canada: University of Ottawa,; 2004
    Search in Google Scholar
  • 17 Stabler SP, Estacio R, Jeffers BW. et al. Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus. Metab Clin Exp 1999; 48: 1096-1101
    CrossrefPubMedSearch in Google Scholar
  • 18 Emoto M, Kanda H, Shoji T. et al. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care 2001; 24: 533-537
    CrossrefPubMedSearch in Google Scholar
  • 19 Okumura KI, Aso Y. High plasma homocysteine concentrations are associated with plasma concentrations of thrombomodulin in patients with type 2 diabetes and link diabetic nephropathy to macroangiopathy. Metab Clin Exp 2003; 52: 1517-1522
    CrossrefPubMedSearch in Google Scholar
  • 20 Aso Y, Yoshida N, Okumura KI. et al. Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia. Clin Chim Acta 2004; 348: 139-145
    CrossrefPubMedSearch in Google Scholar
  • 21 Sandhu JS, Singh I, Aggarwal SP. et al. Plasma homocysteine and insulin in diabetic nephropathy: relationship to body mass index. Renal Failure 2004; 26: 689
    CrossrefPubMedSearch in Google Scholar
  • 22 Mtiraoui N, Ezzidi I, Chaieb M. et al. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Res Clin Pr 2007; 75: 99-106
    CrossrefPubMedSearch in Google Scholar
  • 23 Cho EH, Kim EH, Kim WG. et al. Homocysteine as a risk factor for development of microalbuminuria in type 2 diabetes. Korean Diabetes J 2010; 34: 200-206
    CrossrefPubMedSearch in Google Scholar
  • 24 Li J, Shi M, Zhang H. et al. Relation of homocysteine to early nephropathy in patients with type 2 diabetes. Clin Nephrol. 2012 77. 305-310
    PubMedSearch in Google Scholar
  • 25 Koluman BU, Mutluay R, Derici UB. et al. Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in type 2 diabetes. Clin Nephrol 2013; 80: 9-16
    PubMedSearch in Google Scholar
  • 26 Wang H, Cui K, Xu K. et al. Association between plasma homocysteine and progression of early nephropathy in type 2 diabetic patients. Int J Clin Exp Med 2015; 8: 11174-11180
    PubMedSearch in Google Scholar
  • 27 Ma L, Liu Q, Jiang Y. et al. Genetically elevated circulating homocysteine concentrations increase the risk of diabetic kidney disease in Chinese diabetic patients. J Cell Mol Med 2019; 23: 2794-2800
    CrossrefPubMedSearch in Google Scholar
  • 28 Ma N, Xu N, Yin D. et al. Relationship between plasma total homocysteine and the severity of renal function in Chinese patients with type 2 diabetes mellitus aged≥75 years. Medicine 2020; 99: e20737
    CrossrefPubMedSearch in Google Scholar
  • 29 Ding S, Yang Y, Zheng Y. et al. Diagnostic value of the combined measurement of serum HCY and NRG4 in type 2 diabetes mellitus with early complicating diabetic nephropathy. J Personal Med 2023; 13: 556
    CrossrefPubMedSearch in Google Scholar
  • 30 Li H, Liu C, Zhang J. et al. The association of homocysteine level with the risk of diabetic nephropathy and diabetic retinopathy in Nhanes. Acta Diabetol 2023; 60: 907-916
    CrossrefPubMedSearch in Google Scholar
  • 31 Cao L, Lou X, Zou Z. et al. Folic acid attenuates hyperhomocysteinemia-induced glomerular damage in rats. Microvac Res 2013; 89: 146-152
    CrossrefPubMedSearch in Google Scholar
  • 32 Kaplan P, Tatarkova Z, Sivonova MK. et al. Homocysteine and mitochondria in cardiovascular and cerebrovascular systems. Int J Mol Sci 2020; 21: 7698
    CrossrefPubMedSearch in Google Scholar
  • 33 Ling L, Chen L, Zhang C. et al. High glucose induces podocyte epithelial‑to‑mesenchymal transition by demethylation‑mediated enhancement of MMP9 expression. Mol Med Rep 2018; 17: 5642-5651
    PubMedSearch in Google Scholar
  • 34 Ding N, Xie L, Ma F. et al. miR-30a-5p promotes glomerular podocyte apoptosis via DNMT1-mediated hypermethylation under hyperhomocysteinemia. Acta Biochem Biophys Sin 2022; 54: 126-136
    CrossrefPubMedSearch in Google Scholar
  • 35 Xie L, Ma S, Ding N. et al. Homocysteine induces podocyte apoptosis by regulating miR-1929-5p expression through c-Myc. DNMT1 and EZH2. Mol Ooncol 2021; 15: 3203-3221
    CrossrefPubMedSearch in Google Scholar
  • 36 Li B, Xie H, Wang X. et al. Oxidative stress mediates renal endothelial cell damage in trichloroethylene-sensitized mice. J Toxicol Sci 2019; 44: 317-326
    CrossrefPubMedSearch in Google Scholar
  • 37 Migliori M, Cantaluppi V, Mannari C. et al. Caffeic acid, a phenol found in white wine, modulates endothelial nitric oxide production and protects from oxidative stress-associated endothelial cell injury. Plos One 2015; 10: e117530
    CrossrefPubMedSearch in Google Scholar